2500 — Venus MedTech HangZhou Cashflow Statement
0.000.00%
- HK$1.18bn
- HK$1.40bn
- CNY470.83m
Annual cashflow statement for Venus MedTech HangZhou, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -186 | -378 | -1,156 | -735 | -741 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 23.9 | -4.13 | 439 | 121 | 345 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -113 | -127 | -125 | -121 | 309 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -237 | -457 | -729 | -610 | 23.7 |
| Capital Expenditures | -124 | -145 | -179 | -263 | -41.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -174 | -508 | -893 | -84 | 21.7 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -298 | -653 | -1,072 | -347 | -19.9 |
| Financing Cash Flow Items | -251 | 45.3 | -66.5 | -43.7 | -28.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 928 | 1,391 | 635 | -174 | -487 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 295 | 247 | -1,076 | -1,105 | -476 |